Φαρμακευτικές Υπηρεσίες


General information on the regulatory requirements for the submission of applications for the renewal of a marketing authorisation are available in “Volume 2A, Chapter 1 (Marketing Authorisation) of the Notice to Applicants” and the relevant applications are available in “Volume 2B of the Notice to Applicants” of the European Commission website ( https://ec.europa.eu/health/documents/eudralex_en )

Submission via CESP and the inclusion of the signed cover letter and the signed eAF in the CESP submission are mandatory.

During the validation of the content, the completeness and correctness of the electronic dossier is checked in accordance with the CMDh guidelines, which are located at the following link https://www.hma.eu/95.html

Additional national requirements are published on the CMDh website and are as follows:

1) A person responsible for pharmacovigilance resident in Cyprus

2) A person responsible for the provision of scientific services resident in Cyprus









Share